Albion Financial Group UT lowered its position in Kimberly-Clark Co. (NYSE:KMB – Free Report) by 0.7% in the fourth quarter, Holdings Channel reports. The fund owned 36,008 shares of the company’s stock after selling 248 shares during the period. Albion Financial Group UT’s holdings in Kimberly-Clark were worth $4,718,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Park Avenue Securities LLC increased its holdings in Kimberly-Clark by 77.4% in the fourth quarter. Park Avenue Securities LLC now owns 13,786 shares of the company’s stock valued at $1,807,000 after buying an additional 6,016 shares during the last quarter. Pensionfund Sabic increased its holdings in shares of Kimberly-Clark by 45.5% in the 4th quarter. Pensionfund Sabic now owns 12,800 shares of the company’s stock valued at $1,677,000 after acquiring an additional 4,000 shares during the last quarter. Barclays PLC increased its holdings in shares of Kimberly-Clark by 19.4% in the 3rd quarter. Barclays PLC now owns 1,681,671 shares of the company’s stock valued at $239,267,000 after acquiring an additional 273,813 shares during the last quarter. Vest Financial LLC raised its position in shares of Kimberly-Clark by 6.5% during the 3rd quarter. Vest Financial LLC now owns 347,269 shares of the company’s stock worth $49,409,000 after acquiring an additional 21,339 shares in the last quarter. Finally, Aprio Wealth Management LLC lifted its stake in Kimberly-Clark by 20.0% during the fourth quarter. Aprio Wealth Management LLC now owns 2,792 shares of the company’s stock worth $366,000 after purchasing an additional 466 shares during the last quarter. Institutional investors and hedge funds own 76.29% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have weighed in on the stock. Piper Sandler cut their price objective on shares of Kimberly-Clark from $175.00 to $161.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. JPMorgan Chase & Co. cut their price target on shares of Kimberly-Clark from $140.00 to $124.00 and set an “underweight” rating on the stock in a research note on Thursday, January 16th. Barclays decreased their price objective on shares of Kimberly-Clark from $144.00 to $132.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Royal Bank of Canada reiterated an “outperform” rating and set a $165.00 target price on shares of Kimberly-Clark in a research report on Wednesday, October 23rd. Finally, UBS Group reduced their target price on Kimberly-Clark from $151.00 to $132.00 and set a “neutral” rating for the company in a report on Thursday, January 16th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $143.71.
Insiders Place Their Bets
In other news, VP Andrew Drexler sold 3,000 shares of Kimberly-Clark stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $139.01, for a total transaction of $417,030.00. Following the completion of the sale, the vice president now directly owns 5,053 shares in the company, valued at approximately $702,417.53. This trade represents a 37.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.62% of the company’s stock.
Kimberly-Clark Trading Down 0.6 %
NYSE KMB opened at $126.47 on Wednesday. The company has a quick ratio of 0.55, a current ratio of 0.83 and a debt-to-equity ratio of 4.77. The stock has a market capitalization of $42.17 billion, a P/E ratio of 16.40, a P/E/G ratio of 3.56 and a beta of 0.41. Kimberly-Clark Co. has a 52-week low of $117.67 and a 52-week high of $149.30. The firm has a 50-day moving average price of $132.29 and a 200 day moving average price of $137.91.
Kimberly-Clark (NYSE:KMB – Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The company reported $1.83 EPS for the quarter, beating the consensus estimate of $1.69 by $0.14. Kimberly-Clark had a return on equity of 198.59% and a net margin of 12.97%. The business had revenue of $4.95 billion during the quarter, compared to analysts’ expectations of $5.06 billion. During the same period last year, the firm earned $1.74 EPS. The company’s quarterly revenue was down 3.5% compared to the same quarter last year. Equities research analysts expect that Kimberly-Clark Co. will post 7.32 EPS for the current year.
Kimberly-Clark Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, January 3rd. Shareholders of record on Friday, December 6th were issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.86%. The ex-dividend date of this dividend was Friday, December 6th. Kimberly-Clark’s dividend payout ratio (DPR) is currently 63.29%.
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Further Reading
- Five stocks we like better than Kimberly-Clark
- 5 discounted opportunities for dividend growth investors
- Rivian: Weathering the Storm, Poised for Growth?
- How to Invest in the FAANG Stocks
- Avient Stock: Manufacturing Play With Double-Digit Upside
- What is diluted earnings per share (Diluted EPS)?
- Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Co. (NYSE:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.